The evolution of diabetic retinopathy screening.

Diabetic retinopathy (DR) is a leading cause of preventable blindness and has emerged as a global health challenge, necessitating the development of robust management strategies. As DR prevalence continues to rise, advancements in screening methods have become increasingly critical for timely detection and intervention. This review examines three key advancements in DR screening: a shift from specialist to generalist approach, the adoption of telemedicine strategies for expanded access and enhanced efficiency, and the integration of artificial intelligence (AI). In particular, AI offers unprecedented benefits in the form of sustainability and scalability for not only DR screening but other aspects of eye health and the medical field as a whole. Though there remain barriers to address, AI holds vast potential for reshaping DR screening and significantly improving patient outcomes globally.